HORIBA Instruments Inc. 5390012248 DRI Cannabinoids 1 X 5 mL
The HORIBA Instruments, Inc. 5390012248 DRI® Cannabinoids calibration standard is designed for use in clinical laboratories and medical facilities, providing a reliable solution for the calibration and validation of the DRI Cannabinoid Assay. This product is specifically intended for in vitro diagnostic use, aiming to detect THC in human urine samples with high accuracy. Its standout benefit lies in its ability to ensure the precision and reliability of cannabinoid assays, which is crucial for medical and legal applications.
The DRI® Cannabinoids standard serves as a calibration and validation tool for the DRI Cannabinoid Assay, which is designed to detect the presence of THC in human urine samples. This standard is essential for laboratories to verify the accuracy and precision of their assay results, ensuring compliance with regulatory requirements and maintaining the integrity of diagnostic testing.
Key Features
- Provides a reliable calibration standard for the DRI Cannabinoid Assay
- Designed for in vitro diagnostic use in clinical laboratories and medical facilities
- Enables accurate detection of THC in human urine samples
- Supports compliance with regulatory requirements for diagnostic testing
- Enhances the precision and reliability of cannabinoid assays
- Supplied in a 5 mL volume, suitable for laboratory use
- Concentration of 20ng for precise calibration and validation
Product Specifications
• Dimensions: Not specified • Weight: Not specified • Materials: Not specified • Compliance: For in vitro diagnostic use, intended for calibration and validation of the DRI Cannabinoid Assay • Compatibility: Compatible with the DRI Cannabinoid Assay for detecting THC in human urine samplesIdeal For
• Clinical laboratories • Medical facilities • Forensic laboratories • Research institutions • Any setting requiring accurate detection of THC in human urine samples for diagnostic or legal purposesShare Product Link: